Cefepime versus ceftazidime as empirical therapy for fever in neutropenic patients with haematological malignancies

Indian Journal of Hematology and Blood Transfusion

Volumn 23, Issue 3-4, 2007, Pages 104-106

  Ghalaut, P S ^a,b   Chaudhry, Uma ^a   Ghalaut, Veena Singh ^a   Aggarwal, Sameer ^a,b   Sood, Vinny ^a,b   Dixit, Gaurav ^a,b  

^a POST GRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b NONE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CEFEPIME; CEFTAZIDIME;

ADULT; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEBRILE NEUTROPENIA; FEVER; HEMATOLOGIC MALIGNANCY; HUMAN; MONOTHERAPY; NEUTROPHIL COUNT; OPEN STUDY; RANDOMIZED CONTROLLED TRIAL;

EID: 51049124477     PISSN: 09714502     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12288-008-0007-x     Document Type: Article

References (8)

1. Bergumans T, Scolier SP (2002) Myelosuppression and infective complications. In: Souhami RL, Tannok I, Hohznberger P, Horiot SC, editors. Oxford Textbook of oncology. 2nd edn. Oxford University Press Inc., New York; Vol. 1: Pp. 575-89
2. Finberg R (2005) Infections in patients with cancer. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, editors. Harrison's Principles of Internal Medicine. Vol.1, 16th edn. New York: McGraw Hill; p 489-496
3. Fu Der Wang, Cheng Y Liu, Hui Chi Hsu, Iyh Pyng Gau, Wing Keung Chan, Ming Li Haung (1999) A comparative study of Cefepime versus Ceftezadime as empirical therapy in febrile neutropenic patients. Chemotherapy 45:370-379
4. Jandula B, Martino R, Gurgi M, Manteiga R, Sierra J (2001) Treatment of febrile neutropenia with cefepime monotherapy. Chemotherapy 47:226-231
5. Kebudi R, Gorgun O, Ayan I, Gurler N, Akici F, Toreci K (2001) Randomized comparison of cefepime versus Ceftezadime monotherapy for fever and neutropenia in children with solid tumours. Med Pediatr Oncol 36(4):434-441
6. Cordonniek C, Herbrecht R, Pico JL (1997) Cefepime/Amikacin versus Ceftazidime/Amikacin as empirical therapy for febrile episodes in neutropenic patients. A comparative study. The French Cefepime Study Group. Gun lnf Dis 24:41-51
7. Chandrasekhar PH, Arrow PM Cefepime versus Ceftezadime as empirical therapy for fever in neutropenic patients with cancer. Annals of Pharmacotherapy 34(9):989-995
8. Motalar J, Segura A, Bosch C, Galan A, Juano, Molins C et al (2002) Cefepime monotherapy as an empirical initial treatment of patients with febrile neutropenia. Med Oncol 19(3): 161-166